ASCO - Dose Dense Therapy, Neoadjuvant Therapy and Biologics

This will be my final report regarding my experience at the  ASCO 2012  meeting. 

Instead of personally writing about what I heard at  June second's Upfront Treatment of Ovarian Cancer an International Consensus and Variation Session Educational Session I thought it best to just share a link to a wonderful article ( plus it has cool graphics too) on the ASCO site . This session was presented by Drs. Armstrong ( IP therapy) , Fujiwara ( Dose Dense and Neoadjuvant  therapy)  and Rustin ( Parp inhibitors and Bevacizumab). You can tell how important the ASCO committee felt this was since it was held in  E Arie Crown Theater which seats over 4000 people.

So please click on the link below and read about those topics.

http://chicago2012.asco.org/ASCODailyNews/upfrontovarian.aspx

Dee
Every Day is a Blessing!